Kun Qian

919 total citations
38 papers, 744 citations indexed

About

Kun Qian is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Kun Qian has authored 38 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Kun Qian's work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease Diagnosis and Treatment (7 papers) and Liver Disease and Transplantation (6 papers). Kun Qian is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease Diagnosis and Treatment (7 papers) and Liver Disease and Transplantation (6 papers). Kun Qian collaborates with scholars based in China, United States and Germany. Kun Qian's co-authors include Chuansheng Zheng, Xiangliang Yang, Bin Xiong, Yanbing Zhao, Anchao Zhang, Jiawei Liu, Jun Xiang, Sheng Su, Hao Tang and Yingbiao Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Neuron.

In The Last Decade

Kun Qian

37 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun Qian China 13 244 189 144 124 92 38 744
Ruomi Guo China 16 175 0.7× 198 1.0× 106 0.7× 62 0.5× 113 1.2× 53 728
Dongwei Gao United States 19 248 1.0× 211 1.1× 42 0.3× 66 0.5× 109 1.2× 30 830
Hongyun Huang China 15 175 0.7× 210 1.1× 43 0.3× 83 0.7× 77 0.8× 43 680
Naijian Ge China 18 151 0.6× 192 1.0× 149 1.0× 181 1.5× 67 0.7× 45 761
Dan Yao China 13 492 2.0× 532 2.8× 164 1.1× 198 1.6× 76 0.8× 45 1.3k
Hui Dong China 16 82 0.3× 277 1.5× 165 1.1× 34 0.3× 21 0.2× 55 735
June Seok Heo South Korea 18 257 1.1× 548 2.9× 152 1.1× 19 0.2× 184 2.0× 31 1.3k
Yu‐Fen Chung Taiwan 8 84 0.3× 333 1.8× 67 0.5× 342 2.8× 83 0.9× 11 917
Mingda Han United States 21 189 0.8× 621 3.3× 108 0.8× 12 0.1× 68 0.7× 40 1.1k
Hui Dong China 13 301 1.2× 282 1.5× 147 1.0× 10 0.1× 81 0.9× 29 737

Countries citing papers authored by Kun Qian

Since Specialization
Citations

This map shows the geographic impact of Kun Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Qian more than expected).

Fields of papers citing papers by Kun Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Qian. The network helps show where Kun Qian may publish in the future.

Co-authorship network of co-authors of Kun Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Qian. A scholar is included among the top collaborators of Kun Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Qian. Kun Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Xin & Kun Qian. (2025). Hepatic Arterial Infusion Chemotherapy Combined Apatinib/Camrelizumab for Recurrent Hepatocellular Carcinoma After Hepatectomy. Journal of Hepatocellular Carcinoma. Volume 12. 1205–1215.
2.
Sun, Bo, Kun Qian, Meirong Zhang, et al.. (2025). Lipoic Acid/Choline Ionic Liquid Enhanced Intratumoral Heat/Mass Transfer for Suppressing Thermo‐Mediated Tumor Relapse and Metastasis. Advanced Materials. 37(13). e2415157–e2415157. 2 indexed citations
3.
Ren, Yanqiao, Ziyi Liu, Xuefeng Kan, et al.. (2022). Addition of Camrelizumab to Transarterial Chemoembolization in Hepatocellular Carcinoma With Untreatable Progression. Technology in Cancer Research & Treatment. 21. 2213873273–2213873273. 7 indexed citations
4.
Zhang, Hongsen, Yanqiao Ren, Han Li, Chuansheng Zheng, & Kun Qian. (2022). Renal and hepatic artery embolization with Pickering gel emulsion of lipiodol in rabbit. BMC Cancer. 22(1). 1300–1300. 5 indexed citations
5.
Qian, Kun, et al.. (2021). Quantitative dual-energy CT for evaluating hepatocellular carcinoma after transarterial chemoembolization. Scientific Reports. 11(1). 11127–11127. 16 indexed citations
8.
Chen, Lei, Kun Qian, Xuefeng Kan, et al.. (2021). Caudate Lobe Hepatocellular Carcinoma Treated with Sequential Transarterial Chemoembolization and Iodine 125 Seeds Implantation: A Single-Center Retrospective Study. Cancer Management and Research. Volume 13. 3901–3912. 2 indexed citations
10.
Chen, Minjiang, Feng Zhang, Jingjing Song, et al.. (2021). Image-Guided Peri-Tumoral Radiofrequency Hyperthermia-Enhanced Direct Chemo-Destruction of Hepatic Tumor Margins. Frontiers in Oncology. 11. 593996–593996. 5 indexed citations
11.
Qian, Kun, et al.. (2020). Image-guided locoregional non-intravascular interventional treatments for hepatocellular carcinoma: Current status. SHILAP Revista de lepidopterología. 4(1). 1–7. 6 indexed citations
12.
Kan, Xuefeng, Yong Wang, Ping Han, et al.. (2019). <p>Combined ultrasound/computed tomography guidance in percutaneous radiofrequency ablation after transarterial chemoembolization for hepatocellular carcinoma in the hepatic dome</p>. Cancer Management and Research. Volume 11. 7751–7757. 12 indexed citations
13.
Zhang, Hongsen, Kun Qian, Yiming Liu, et al.. (2019). <p>Transcatheter arterial embolization combined with hypoxia-replicative oncolytic adenovirus perfusion enhances the therapeutic effect of hepatic carcinoma</p>. Cancer Management and Research. Volume 11. 981–996. 6 indexed citations
14.
Li, Jiaxin, Hong Wu, Kun Qian, & Yong Zeng. (2018). Contrast enhanced intraoperative ultrasonography-guided radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy through percutaneous or open approach: a retrospective cohort study. 11(12). 1 indexed citations
16.
Liu, Yiming, Xiaole Peng, Kun Qian, et al.. (2016). Temperature sensitive p(N-isopropylacrylamide-co-acrylic acid) modified gold nanoparticles for trans-arterial embolization and angiography. Journal of Materials Chemistry B. 5(5). 907–916. 24 indexed citations
18.
19.
Yang, Ying, Xiaogang Shu, Dan Liu, et al.. (2012). EPAC Null Mutation Impairs Learning and Social Interactions via Aberrant Regulation of miR-124 and Zif268 Translation. Neuron. 73(4). 774–788. 156 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026